Lycine
RxNorm 1512
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1512 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Lycine.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
INPrescribable
Ingredient (IN):
Betaine
(Atom ID: 12253848)
PTPrescribable
Designated preferred name (PT):
Betaine
(Atom ID: 46414)
FNPrescribable
Full form of descriptor (FN):
Betaine (substance)
(Atom ID: 46432)
PTPrescribable
Designated preferred name (PT):
Betaine-containing product
(Atom ID: 10798031)
SYPrescribable
Synonym (SY):
Lycine
(Atom ID: 46426)
SYPrescribable
Synonym (SY):
Oxyneurine
(Atom ID: 46429)
FNPrescribable
Full form of descriptor (FN):
Product containing betaine (medicinal product)
(Atom ID: 9723545)
Patient Education
Betaine
Betaine is used to treat homocystinuria (an inherited condition in which the body cannot break down a certain protein, causing build-up of homocysteine in the blood). Increased amounts of homocysteine in the body can cause symptoms such as extreme tiredness, seizures, dislocation of the lens of the eye, abnormal bone structure, osteoporosis (weak bones), blood clots, or decreased weight or rate of weight gain and slowed development in children. Betaine is in a class of medications called nutrients. It works by decreasing the amount of homocysteine in the blood.
[Learn More]
* Please review the disclaimer below.